In the press

Matthew Read comments on the latest update from HRI in Investment Week

Biotech trusts top performance charts in February

Matthew Read comments on the update from HRI in Linus Uhlig’s article:

“It is sensible that the manager has begun reducing some of Herald’s less liquid positions to limit the impact of any forced disposals, whether through a backstop tender or a larger-than-expected cash exit,”

Read the article here